Tumor Derived Mutations of Protein Tyrosine Phosphatase Receptor Type K Affect Its Function and Alter Sensitivity to Chemotherapeutics in Glioma

Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using Genomics

(2012) Mahfoud Assem et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth

(2012) Guillem Ramis et al.   PLoS One

Gefitinib induces apoptosis in human glioma cells by targeting Bad phosphorylation

(2011) Cheng-Yi Chang et al.   JOURNAL OF NEURO-ONCOLOGY

A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells

(2011) Jean H Overmeyer et al.   Molecular Cancer

Protein–tyrosine phosphatase-kappa regulates CD4+ T cell development through ERK1/2-mediated signaling

(2009) Namjil Erdenebayar et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Proteolytic Cleavage of Protein Tyrosine Phosphatase   Regulates Glioblastoma Cell Migration

(2009) A. M. Burgoyne et al.   CANCER RESEARCH

Tyrosine phosphorylation: thirty years and counting

(2009) Tony Hunter   CURRENT OPINION IN CELL BIOLOGY

Targeting multiple kinases in glioblastoma multiforme

(2009) Sith Sathornsumetee et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Therapeutic strategies for inhibiting invasion in glioblastoma

(2009) Jan Drappatz et al.   Expert Review of Neurotherapeutics

PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic β-catenin and affects membrane distribution of β-catenin/E-cadherin complexes in cancer cells

(2008) Luisa Novellino et al.   CELLULAR SIGNALLING

Metalloproteinase- and γ-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z

(2008) Jeremy Pak Hong Chow et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE